- Filed
- May 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 2, 2024 | 64.81M sh |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.74B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $3.79B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $5.52B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $5.27B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $9.76B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $9.53B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $221.82M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $158.94M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 68.18M sh |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $57.37M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $42.35M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.63 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.63 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $23.29M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$35.99M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $245.76M |